SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-125303
Filing Date
2017-04-17
Accepted
2017-04-17 09:01:00
Documents
11
Period of Report
2017-05-23
Effectiveness Date
2017-04-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d333443ddef14a.htm DEF 14A 1505671
2 GRAPHIC g333443g10q46.jpg GRAPHIC 63826
3 GRAPHIC g333443g14d64.jpg GRAPHIC 56874
4 GRAPHIC g333443g17u52.jpg GRAPHIC 12025
5 GRAPHIC g333443g25b38.jpg GRAPHIC 15706
6 GRAPHIC g333443g48j77.jpg GRAPHIC 101415
7 GRAPHIC g333443g72r19.jpg GRAPHIC 11696
8 GRAPHIC g333443g88f37.jpg GRAPHIC 14106
9 GRAPHIC g333443g92s40.jpg GRAPHIC 76882
10 GRAPHIC g333443g94x94.jpg GRAPHIC 31818
11 GRAPHIC g333443g95p98.jpg GRAPHIC 16652
  Complete submission text file 0001193125-17-125303.txt   2060611
Mailing Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Business Address 311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

IRS No.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26224 | Film No.: 17763639
SIC: 3826 Laboratory Analytical Instruments